儿童COVID-19患者院内复苏的结局
该研究基于Get-With-The-Guidelines®-Resuscitation注册数据库,纳入2020年3月至12月因院内心脏骤停(IHCA)或灌注不良的心动过缓接受CPR的儿童患者共1328例CPR事件(IHCA 590例,灌注不良的心动过缓738例),其中46例(IHCA 32例,心动过缓14例)为疑似/确诊COVID-19感染。采用多因素分层回归(医院站点为随机效应)比较存活至出院和ROSC(≥20分钟)。结果显示,合并与不合并COVID-19感染的患儿存活至出院率相似(39.1% vs 44.9%;调整RR 1.14 [95%CI 0.55-2.36]),IHCA和灌注不良的心动过缓亚组调整RR分别为1.03和1.05(交互作用P=0.96);ROSC率也相似(67.4% vs 76.9%;调整RR 0.87 [0.43, 1.77]),亚组调整RR分别为0.95和0.86(交互作用P=0.26)。结论认为,在该大型多中心国家注册研究中,COVID-19感染与儿童CPR患者ROSC或出院存活率降低无关。
要点
- 儿童院内CPR事件共1328例,其中疑似/确诊COVID-19感染46例(IHCA 32例,心动过缓14例)。
- 合并与不合并COVID-19感染的患儿存活至出院率相似(39.1% vs 44.9%;调整RR 1.14 [95%CI 0.55-2.36])。
- 合并与不合并COVID-19感染的患儿ROSC率相似(67.4% vs 76.9%;调整RR 0.87 [0.43, 1.77])。
- IHCA和灌注不良的心动过缓亚组的存活至出院调整RR分别为1.03和1.05(交互作用P=0.96),ROSC调整RR分别为0.95和0.86(交互作用P=0.26)。
- 该多中心注册研究提示,儿童CPR时COVID-19感染与ROSC或出院存活率降低无关。
适用人群与场景
- 2020年3月至12月在Get-With-The-Guidelines®-Resuscitation注册系统中因IHCA或灌注不良的心动过缓接受CPR的儿童患者。
- 共纳入1328例CPR事件(IHCA 590例,灌注不良的心动过缓738例),其中46例(IHCA 32例,心动过缓14例)为疑似/确诊COVID-19感染。
诊断标准与关键阈值
- IHCA:需接受CPR的院内心脏骤停。
- 灌注不良的心动过缓:需接受CPR的心动过缓。
研究设计与关键结果
- 研究类型:基于Get-With-The-Guidelines®-Resuscitation注册数据库的多中心队列研究。
- 人群:2020年3月至12月因IHCA或灌注不良的心动过缓接受CPR的儿童患者,共1328例CPR事件(IHCA 590例,心动过缓738例),其中46例(IHCA 32例,心动过缓14例)为疑似/确诊COVID-19感染。
- 主要终点:存活至出院率在COVID-19组与非COVID-19组间相似(39.1% vs 44.9%;调整RR 1.14 [95%CI 0.55-2.36])。
- 亚组分析:IHCA和灌注不良的心动过缓亚组的存活至出院调整RR分别为1.03和1.05(交互作用P=0.96)。
- 次要终点:ROSC(≥20分钟)率在两组间相似(67.4% vs 76.9%;调整RR 0.87 [0.43, 1.77]),IHCA和心动过缓亚组调整RR分别为0.95和0.86(交互作用P=0.26)。
证据类型、等级与局限
- 证据类型:基于多中心注册数据库的队列研究。
- 统计方法:多因素分层回归,医院站点为随机效应,患者和心脏骤停变量中双变量关联显著(p < 0.05)者作为固定效应。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该多中心注册研究显示,儿童CPR时合并COVID-19感染与ROSC或出院存活率降低无关,此结果可参照用于复苏决策。
- 对于合并COVID-19感染的儿童IHCA或灌注不良的心动过缓患者,不应仅因COVID-19感染而降低对CPR结局的预期。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Early studies found low survival rates for adults with COVID-19 infection and in-hospital cardiac arrest (IHCA). We evaluated the association of COVID-19 infection on survival outcomes in pediatric patients undergoing cardiopulmonary resuscitation (CPR).
METHODS: Within Get-With-The-Guidelines®-Resuscitation, we identified pediatric patients who underwent CPR for an IHCA or bradycardia with poor perfusion between March and December, 2020. We compared survival outcomes (survival to discharge and return of spontaneous circulation for ≥20 minutes [ROSC]) between patients with suspected/confirmed COVID-19 infection and non-COVID-19 patients using multivariable hierarchical regression, with hospital site as a random effect and patient and cardiac arrest variables with a significant (p < 0.05) bivariate association as fixed effects.
RESULTS: Overall, 1328 pediatric in-hospital CPR events were identified (590 IHCA, 738 bradycardia with poor perfusion), of which 46 (32 IHCA, 14 bradycardia) had suspected/confirmed COVID-19 infection. Rates of survival to discharge were similar between those with and without COVID-19 infection (39.1% vs. 44.9%; adjusted RR, 1.14 [95% CI: 0.55-2.36]), and these estimates were similar for those with IHCA and bradycardia with poor perfusion (adjusted RRs of 1.03 and 1.05; interaction p = 0.96). Rates of ROSC were also similar between pediatric patients with and without COVID-19 overall (67.4% vs. 76.9%; adjusted RR, 0.87 [0.43, 1.77]), and for the subgroups with IHCA or bradycardia requiring CPR (adjusted RRs of 0.95 and 0.86, interaction p = 0.26).
CONCLUSIONS: In a large multicenter national registry of CPR events, COVID-19 infection was not associated with lower rates of ROSC or survival to hospital discharge in pediatric patients undergoing CPR.
参考来源
- El-Zein RS, Chan ML, Su L, et al. Outcomes of pediatric patients with COVID-19 and in-hospital cardiopulmonary resuscitation. Resuscitation. 2022. PMID: 35227819. doi:10.1016/j.resuscitation.2022.02.018
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。